Spandidos Publications Logo
  • About
    • About Spandidos
    • Aims and Scopes
    • Abstracting and Indexing
    • Editorial Policies
    • Reprints and Permissions
    • Job Opportunities
    • Terms and Conditions
    • Contact
  • Journals
    • All Journals
    • Oncology Letters
      • Oncology Letters
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Oncology
      • International Journal of Oncology
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Molecular and Clinical Oncology
      • Molecular and Clinical Oncology
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Experimental and Therapeutic Medicine
      • Experimental and Therapeutic Medicine
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Molecular Medicine
      • International Journal of Molecular Medicine
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Biomedical Reports
      • Biomedical Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Oncology Reports
      • Oncology Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Molecular Medicine Reports
      • Molecular Medicine Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • World Academy of Sciences Journal
      • World Academy of Sciences Journal
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Functional Nutrition
      • International Journal of Functional Nutrition
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Epigenetics
      • International Journal of Epigenetics
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Medicine International
      • Medicine International
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
  • Articles
  • Information
    • Information for Authors
    • Information for Reviewers
    • Information for Librarians
    • Information for Advertisers
    • Conferences
  • Language Editing
Spandidos Publications Logo
  • About
    • About Spandidos
    • Aims and Scopes
    • Abstracting and Indexing
    • Editorial Policies
    • Reprints and Permissions
    • Job Opportunities
    • Terms and Conditions
    • Contact
  • Journals
    • All Journals
    • Biomedical Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Experimental and Therapeutic Medicine
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Epigenetics
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Functional Nutrition
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Molecular Medicine
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Oncology
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Medicine International
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Molecular and Clinical Oncology
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Molecular Medicine Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Oncology Letters
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Oncology Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • World Academy of Sciences Journal
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
  • Articles
  • Information
    • For Authors
    • For Reviewers
    • For Librarians
    • For Advertisers
    • Conferences
  • Language Editing
Login Register Submit
  • This site uses cookies
  • You can change your cookie settings at any time by following the instructions in our Cookie Policy. To find out more, you may read our Privacy Policy.

    I agree
Search articles by DOI, keyword, author or affiliation
Search
Advanced Search
presentation
Oncology Letters
Join Editorial Board Propose a Special Issue
Print ISSN: 1792-1074 Online ISSN: 1792-1082
Journal Cover
September-2022 Volume 24 Issue 3

Full Size Image

Sign up for eToc alerts
Recommend to Library

Journals

International Journal of Molecular Medicine

International Journal of Molecular Medicine

International Journal of Molecular Medicine is an international journal devoted to molecular mechanisms of human disease.

International Journal of Oncology

International Journal of Oncology

International Journal of Oncology is an international journal devoted to oncology research and cancer treatment.

Molecular Medicine Reports

Molecular Medicine Reports

Covers molecular medicine topics such as pharmacology, pathology, genetics, neuroscience, infectious diseases, molecular cardiology, and molecular surgery.

Oncology Reports

Oncology Reports

Oncology Reports is an international journal devoted to fundamental and applied research in Oncology.

Experimental and Therapeutic Medicine

Experimental and Therapeutic Medicine

Experimental and Therapeutic Medicine is an international journal devoted to laboratory and clinical medicine.

Oncology Letters

Oncology Letters

Oncology Letters is an international journal devoted to Experimental and Clinical Oncology.

Biomedical Reports

Biomedical Reports

Explores a wide range of biological and medical fields, including pharmacology, genetics, microbiology, neuroscience, and molecular cardiology.

Molecular and Clinical Oncology

Molecular and Clinical Oncology

International journal addressing all aspects of oncology research, from tumorigenesis and oncogenes to chemotherapy and metastasis.

World Academy of Sciences Journal

World Academy of Sciences Journal

Multidisciplinary open-access journal spanning biochemistry, genetics, neuroscience, environmental health, and synthetic biology.

International Journal of Functional Nutrition

International Journal of Functional Nutrition

Open-access journal combining biochemistry, pharmacology, immunology, and genetics to advance health through functional nutrition.

International Journal of Epigenetics

International Journal of Epigenetics

Publishes open-access research on using epigenetics to advance understanding and treatment of human disease.

Medicine International

Medicine International

An International Open Access Journal Devoted to General Medicine.

Journal Cover
September-2022 Volume 24 Issue 3

Full Size Image

Sign up for eToc alerts
Recommend to Library

  • Article
  • Citations
    • Cite This Article
    • Download Citation
    • Create Citation Alert
    • Remove Citation Alert
    • Cited By
  • Similar Articles
    • Related Articles (in Spandidos Publications)
    • Similar Articles (Google Scholar)
    • Similar Articles (PubMed)
  • Download PDF
  • Download XML
  • View XML
Article Open Access

Relationship between pre‑operative glycated haemoglobin and surgical site infection in patients undergoing elective colon cancer surgery

  • Authors:
    • Chee Mei Cheong
    • Allan M. Golder
    • Paul G. Horgan
    • Campbell S.D. Roxburgh
    • Donald C. McMillan
  • View Affiliations / Copyright

    Affiliations: Academic Unit of Surgery, University of Glasgow, Glasgow Royal Infirmary, Glasgow G31 2ER, United Kingdom
    Copyright: © Cheong et al. This is an open access article distributed under the terms of Creative Commons Attribution License.
  • Article Number: 296
    |
    Published online on: July 5, 2022
       https://doi.org/10.3892/ol.2022.13416
  • Expand metrics +
Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )
Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )
Cited By (CrossRef): 0 citations Loading Articles...

This article is mentioned in:



Abstract

Surgical site infections remain a significant cause of morbidity following colon cancer surgery. Although diabetes has been recognised as a risk factor, patients with asymptomatic diabetes are likely underdiagnosed. The aim of the present study was to determine the relationship between preoperative glycated haemoglobin (HbA1C), clinicopathological characteristics and the influence on surgical site infection in a cohort of patients undergoing potentially curative colon cancer surgery. Patients who underwent elective, potentially curative colon cancer surgery between January 2011 and December 2014 were assessed for HbA1C levels (mmol/mol) measured within 3 months preoperatively. Clinicopathological data were recorded in a maintained database. A multivariate binary logistic regression model was used to assess the relationship between HbA1C, clinicopathological characteristics and surgical site infections. A total of 362 patients had HbA1C levels preoperatively recorded. HbA1C was significantly associated with body mass index (BMI), diabetes, smoking status, visceral fat area and skeletal muscle index. As determined by multivariate analysis, preoperative HbA1C levels remained independently associated with an increased risk of surgical site infections (OR 1.69, 95% CI 1.05‑2.7; P=0.031) together with BMI (OR 1.91, 95% CI 1.36‑2.67; P<0.001). Notably, in the present study, tumour‑based factors, such as tumour location and TNM status, were not associated with infective complications. By contrast, host factors, such as BMI and pre‑operative HbA1C were associated with surgical site infections suggesting that these factors were of more importance in determining short‑term outcomes. In conclusion, objective measurements of BMI and HbA1C effectively stratified the risk of developing surgical site infection from 8 to 59%; therefore, HbA1C levels should be determined to allow for preoperative optimisation.
View Figures

Figure 1

Figure 2

Figure 3

View References

1 

Chakrabarti S, Peterson CY, Sriram D and Mahipal A: Early stage colon cancer: Current treatment standards, evolving paradigms, and future directions. World J Gastrointest Oncol. 12:808–832. 2020. View Article : Google Scholar : PubMed/NCBI

2 

Benson AB, Venook AP, Al-Hawary MM, Arain MA, Chen YJ, Ciombor KK, Cohen S, Cooper HS, Deming D, Farkas L, et al: Colon cancer, version 2.2021, NCCN clinical practice guidelines in oncology. J Natl Compr Canc Netw. 19:329–359. 2021. View Article : Google Scholar : PubMed/NCBI

3 

Cancer Research UK: Chemotherapy, radiotherapy and surgical tumour resection in England. Journal; 2020

4 

McSorley ST, Horgan PG and McMillan DC: The impact of the type and severity of postoperative complications on long-term outcomes following surgery for colorectal cancer: A systematic review and meta-analysis. Crit Rev Oncol Hematol. 97:168–177. 2016. View Article : Google Scholar : PubMed/NCBI

5 

Mills KT, Bellows CF, Hoffman AE, Kelly TN and Gagliardi G: Diabetes mellitus and colorectal cancer prognosis: A meta-analysis. Dis Colon Rectum. 56:1304–1319. 2013. View Article : Google Scholar : PubMed/NCBI

6 

Becker DJ, Iyengar AD, Punekar SR, Kaakour D, Griffin M, Nicholson J and Gold HT: Diabetes mellitus and colorectal carcinoma outcomes: A meta-analysis. Int J Colorectal Dis. 35:1989–1999. 2020. View Article : Google Scholar : PubMed/NCBI

7 

Zhu B, Wu X, Wu B, Pei D, Zhang L and Wei L: The relationship between diabetes and colorectal cancer prognosis: A meta-analysis based on the cohort studies. PLoS One. 12:e01760682017. View Article : Google Scholar : PubMed/NCBI

8 

IDF Diabetes Atlas, . International Diabetes Federation. 9th edition. Brussels: 2019

9 

Duan D, Kengne AP and Echouffo-Tcheugui JB: Screening for diabetes and prediabetes. Endocrinol Metab Clin North Am. 50:369–385. 2021. View Article : Google Scholar : PubMed/NCBI

10 

World Health Organization, International Diabetes Federation, . Definition and diagnosis of diabetes mellitus and intermediate hyperglycaemia: Report of a WHO/IDF consultation. World Health Organization; 2006

11 

World Health Organisation, . Use of glycated haemoglobin(HbA1c) in the diagnosis of diabetes mellitus: Abbreviated Report of a WHO Consultation. World Health Organization; 2011

12 

McPherson RA and Pincus MR: Henry's clinical diagnosis and management by laboratory methods. 22nd edition. Klein MJ and Zhang Y: Elsevier; pp. 232–233. 2022

13 

Public Health England, . Adult Obesity and Type 2 Diabetes. 2014.

14 

Federation ID, . IDF Diabetes Atlas 2021. (10th edition). 2021.

15 

West of Scotland Cancer Network (WoSCAN), . West of Scotland Cancer Network. 2017.

16 

Edge SB, Byrd DR, Compton CC, Fritz AG, Greene FL and Trotti A: AJCC Cancer Staging Manual. 7th edition. Springer; New York, NY: 2010

17 

van der Sijp MP, Bastiaannet E, Mesker WE, van der Geest LG, Breugom AJ, Steup WH, Marinelli AW, Tseng LN, Tollenaar RA, van de Velde CJ and Dekker JW: Differences between colon and rectal cancer in complications, short-term survival and recurrences. Int J Colorectal Dis. 31:1683–1691. 2016. View Article : Google Scholar : PubMed/NCBI

18 

Feeney G, Sehgal R, Sheehan M, Hogan A, Regan M, Joyce M and Kerin M: Neoadjuvant radiotherapy for rectal cancer management. World J Gastroenterol. 25:4850–4869. 2019. View Article : Google Scholar : PubMed/NCBI

19 

American Society of Anesthesiologists, . ASA Physical Status Classification system. 2014.

20 

Golder AM, McMillan DC, Park JH, Mansouri D, Horgan PG and Roxburgh CS: The prognostic value of combined measures of the systemic inflammatory response in patients with colon cancer: An analysis of 1700 patients. Br J Cancer. 124:1828–1835. 2021. View Article : Google Scholar : PubMed/NCBI

21 

Irving BA, Weltman JY, Brock DW, Davis CK, Gaesser GA and Weltman A: NIH ImageJ and Slice-O-Matic computed tomography imaging software to quantify soft tissue. Obesity (Silver Spring). 15:370–376. 2007. View Article : Google Scholar : PubMed/NCBI

22 

NHSScotland Caldicott Guardians, . Principles Into Practice. 2010.

23 

Gustafsson UO, Thorell A, Soop M, Ljungqvist O and Nygren J: Haemoglobin A1c as a predictor of postoperative hyperglycaemia and complications after major colorectal surgery. Br J Surg. 96:1358–1364. 2009. View Article : Google Scholar : PubMed/NCBI

24 

National Institute for Health, Care Excellance, . Routine Preoperative Test for Elective Surgery. 2016.

25 

Lobo DN, Gianotti L, Adiamah A, Barazzoni R, Deutz NE, Dhatariya K, Greenhaff PL, Hiesmayr M, Hjort Jakobsen D, Klek S, et al: Perioperative nutrition: Recommendations from the ESPEN expert group. Clin Nutr. 39:3211–3227. 2020. View Article : Google Scholar : PubMed/NCBI

26 

Kotagal M, Symons RG, Hirsch IB, Umpierrez GE, Dellinger EP, Farrokhi ET and Flum DR; SCOAP-CERTAIN Collaborative, : Perioperative hyperglycemia and risk of adverse events among patients with and without diabetes. Ann Surg. 261:97–103. 2015. View Article : Google Scholar : PubMed/NCBI

27 

Turina M, Miller FN, Tucker C and Polk HC: Effects of hyperglycemia, hyperinsulinemia, and hyperosmolarity on neutrophil apoptosis. Surg Infect (Larchmt). 7:111–121. 2006. View Article : Google Scholar : PubMed/NCBI

28 

Umpierrez GE, Smiley D, Jacobs S, Peng L, Temponi A, Mulligan P, Umpierrez D, Newton C, Olson D and Rizzo M: Randomized study of basal-bolus insulin therapy in the inpatient management of patients with type 2 diabetes undergoing general surgery (RABBIT 2 surgery). Diabetes Care. 34:256–261. 2011. View Article : Google Scholar : PubMed/NCBI

29 

Martin ET, Kaye KS, Knott C, Nguyen H, Santarossa M, Evans R, Bertran E and Jaber L: Diabetes and risk of surgical site infection: A systematic review and meta-analysis. Infection Infect Control Hosp Epidemiol. 37:88–99. 2016. View Article : Google Scholar : PubMed/NCBI

30 

Nugent EK, Hoff JT, Gao F, Massad LS, Case A, Zighelboim I, Mutch DG and Thaker PH: Wound complications after gynecologic cancer surgery. Gynecol Oncol. 121:347–352. 2011. View Article : Google Scholar : PubMed/NCBI

31 

Al-Niaimi AN, Ahmed M, Burish N, Chackmakchy SA, Seo S, Rose S, Hartenbach E, Kushner DM, Safdar N, Rice L and Connor J: Intensive postoperative glucose control reduces the surgical site infection rates in gynecologic oncology patients. Gynecol Oncol. 136:71–76. 2015. View Article : Google Scholar : PubMed/NCBI

32 

O'Donnell RL, Angelopoulos G, Beirne JP, Biliatis I, Bolton H, Bradbury M, Craig E, Gajjar K, Mackintosh ML, MacNab W, et al: Impact of surgical site infection (SSI) following gynaecological cancer surgery in the UK: A trainee-led multicentre audit and service evaluation. BMJ Open. 9:e0248532019. View Article : Google Scholar : PubMed/NCBI

33 

Gallagher M, Jones DJ and Bell-Syer SV: Prophylactic antibiotics to prevent surgical site infection after breast cancer surgery. Cochrane Database Syst Rev. 9:CD0053602019.PubMed/NCBI

34 

Olsen MA, Lefta M, Dietz JR, Brandt KE, Aft R, Matthews R, Mayfield J and Fraser VJ: Risk factors for surgical site infection after major breast operation. J Am Coll Surg. 207:326–335. 2008. View Article : Google Scholar : PubMed/NCBI

35 

Serra-Aracil X, García-Domingo MI, Parés D, Espin-Basany E, Biondo S, Guirao X, Orrego C and Sitges-Serra A: Surgical site infection in elective operations for colorectal cancer after the application of preventive measures. Arch Surg. 146:606–612. 2011. View Article : Google Scholar : PubMed/NCBI

36 

Eto K, Urashima M, Kosuge M, Ohkuma M, Noaki R, Neki K, Ito D, Takeda Y, Sugano H and Yanaga K: Standardization of surgical procedures to reduce risk of anastomotic leakage, reoperation, and surgical site infection in colorectal cancer surgery: A retrospective cohort study of 1189 patients. Int J Colorectal Dis. 33:755–762. 2018. View Article : Google Scholar : PubMed/NCBI

37 

Nelson RL, Gladman E and Barbateskovic M: Antimicrobial prophylaxis for colorectal surgery. Cochrane Database Syst Rev. May 9–2014.(Epub ahead of print). View Article : Google Scholar

38 

Kulkarni N and Arulampalam T: Laparoscopic surgery reduces the incidence of surgical site infections compared to the open approach for colorectal procedures: A meta-analysis. Tech Coloproctol. 24:1017–1024. 2020. View Article : Google Scholar : PubMed/NCBI

39 

Xu Z, Qu H, Kanani G, Guo Z, Ren Y and Chen X: Update on risk factors of surgical site infection in colorectal cancer: A systematic review and meta-analysis. Int J Colorectal Dis. 35:2147–2156. 2020. View Article : Google Scholar : PubMed/NCBI

40 

Kamboj M, Childers T, Sugalski J, Antonelli D, Bingener-Casey J, Cannon J, Cluff K, Davis KA, Dellinger EP, Dowdy SC, et al: Risk of surgical site infection (SSI) following colorectal resection is higher in patients with disseminated cancer: An NCCN member cohort study. Infect Control Hosp Epidemiol. 39:555–562. 2018. View Article : Google Scholar : PubMed/NCBI

41 

Group SDD, . Scottish Diabetes Survey 2020. 2022.

42 

Centre for Perioperative Care, . Guideline for perioperative care for people with diabetes mellitus undergoing elective and emergency surgery. 2021.

43 

World Health Organization, . Global guidelines for the prevention of surgical site infection. World Health Organization; Geneva: 2018

44 

O'Sullivan CJ, Hynes N, Mahendran B, Andrews EJ, Avalos G, Tawfik S, Lowery A and Sultan S: Haemoglobin A1c (HbA1C) in non-diabetic and diabetic vascular patients. Is HbA1C an independent risk factor and predictor of adverse outcome? Eur J Vasc Endovasc Surg. 32:188–197. 2006.PubMed/NCBI

45 

Doyle SL, Bennett AM, Donohoe CL, Mongan AM, Howard JM, Lithander FE, Pidgeon GP, Reynolds JV and Lysaght J: Establishing computed tomography-defined visceral fat area thresholds for use in obesity-related cancer research. Nutr Res. 33:171–179. 2013. View Article : Google Scholar : PubMed/NCBI

46 

Martin L, Birdsell L, Macdonald N, Reiman T, Clandinin MT, McCargar LJ, Murphy R, Ghosh S, Sawyer MB and Baracos VE: Cancer cachexia in the age of obesity: Skeletal muscle depletion is a powerful prognostic factor, independent of body mass index. J Clin Oncol. 31:1539–1547. 2013. View Article : Google Scholar : PubMed/NCBI

47 

Prado CMM, Lieffers JR, McCargar LJ, Reiman T, Sawyer MB, Martin L and Baracos VE: Prevalence and clinical implications of sarcopenic obesity in patients with solid tumours of the respiratory and gastrointestinal tracts: A population-based study. Lancet Oncol. 9:629–635. 2008. View Article : Google Scholar : PubMed/NCBI

Related Articles

  • Abstract
  • View
  • Download
  • Twitter
Copy and paste a formatted citation
Spandidos Publications style
Cheong CM, Golder AM, Horgan PG, Roxburgh CS and McMillan DC: Relationship between pre‑operative glycated haemoglobin and surgical site infection in patients undergoing elective colon cancer surgery. Oncol Lett 24: 296, 2022.
APA
Cheong, C.M., Golder, A.M., Horgan, P.G., Roxburgh, C.S., & McMillan, D.C. (2022). Relationship between pre‑operative glycated haemoglobin and surgical site infection in patients undergoing elective colon cancer surgery. Oncology Letters, 24, 296. https://doi.org/10.3892/ol.2022.13416
MLA
Cheong, C. M., Golder, A. M., Horgan, P. G., Roxburgh, C. S., McMillan, D. C."Relationship between pre‑operative glycated haemoglobin and surgical site infection in patients undergoing elective colon cancer surgery". Oncology Letters 24.3 (2022): 296.
Chicago
Cheong, C. M., Golder, A. M., Horgan, P. G., Roxburgh, C. S., McMillan, D. C."Relationship between pre‑operative glycated haemoglobin and surgical site infection in patients undergoing elective colon cancer surgery". Oncology Letters 24, no. 3 (2022): 296. https://doi.org/10.3892/ol.2022.13416
Copy and paste a formatted citation
x
Spandidos Publications style
Cheong CM, Golder AM, Horgan PG, Roxburgh CS and McMillan DC: Relationship between pre‑operative glycated haemoglobin and surgical site infection in patients undergoing elective colon cancer surgery. Oncol Lett 24: 296, 2022.
APA
Cheong, C.M., Golder, A.M., Horgan, P.G., Roxburgh, C.S., & McMillan, D.C. (2022). Relationship between pre‑operative glycated haemoglobin and surgical site infection in patients undergoing elective colon cancer surgery. Oncology Letters, 24, 296. https://doi.org/10.3892/ol.2022.13416
MLA
Cheong, C. M., Golder, A. M., Horgan, P. G., Roxburgh, C. S., McMillan, D. C."Relationship between pre‑operative glycated haemoglobin and surgical site infection in patients undergoing elective colon cancer surgery". Oncology Letters 24.3 (2022): 296.
Chicago
Cheong, C. M., Golder, A. M., Horgan, P. G., Roxburgh, C. S., McMillan, D. C."Relationship between pre‑operative glycated haemoglobin and surgical site infection in patients undergoing elective colon cancer surgery". Oncology Letters 24, no. 3 (2022): 296. https://doi.org/10.3892/ol.2022.13416
Follow us
  • Twitter
  • LinkedIn
  • Facebook
About
  • Spandidos Publications
  • Careers
  • Cookie Policy
  • Privacy Policy
How can we help?
  • Help
  • Live Chat
  • Contact
  • Email to our Support Team